Green­Light Bio­sciences cel­e­brates man­u­fac­tur­ing mile­stone for Covid-19 boost­er can­di­date

It was late last year when the biotech Green­Light Bio­sciences inked a deal with CD­MO gi­ant Sam­sung Bi­o­log­ics to man­u­fac­ture its mR­NA Covid-19 vac­cine. Now, as Sam­sung pumps more mon­ey in­to its biotech and CD­MO op­er­a­tions, the South Ko­re­an com­pa­ny has com­plet­ed the first com­mer­cial-scale en­gi­neer­ing run for Green­Light’s Covid-19 vac­cine boost­er can­di­date.

Ac­cord­ing to Sam­sung Bi­o­log­ics, Green­Light’s syn­the­sis re­ac­tion had a titer of 12g/L at a com­mer­cial scale and pro­duced 650g of mR­NA. On the back of this test, Green­Light’s Covid boost­er is ex­pect­ed to have da­ta lat­er this year, with man­u­fac­tur­ing at a com­mer­cial scale start­ing soon af­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER